{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:20:16Z","timestamp":1789777216902,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006129","name":"King Gustaf V and Queen Victoria's Masonic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007911","name":"University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007911","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006354","name":"Berth von Kantzows Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["KBF 2019\\u201300446"],"award-info":[{"award-number":["KBF 2019\\u201300446"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pupt.2024.102330","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:12:27Z","timestamp":1728540747000},"page":"102330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-1024","authenticated-orcid":false,"given":"Anders","family":"Kjellberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2492-0923","authenticated-orcid":false,"given":"Allan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7464-4252","authenticated-orcid":false,"given":"Anna","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-1801","authenticated-orcid":false,"given":"Adrian","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-6182","authenticated-orcid":false,"given":"Sarah","family":"Al-Ezerjawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-7631","authenticated-orcid":false,"given":"Emil","family":"Bostr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-3902","authenticated-orcid":false,"given":"Sergiu-Bogdan","family":"Catrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-3713","authenticated-orcid":false,"given":"Peter","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-6181","authenticated-orcid":false,"given":"Kenny Alexandra","family":"Rodriguez-Wallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-9244","authenticated-orcid":false,"given":"Peter","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/21505594.2021.1898790","article-title":"Immune dysregulation and system pathology in COVID-19","volume":"12","author":"Jamal","year":"2021","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.pupt.2024.102330_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/febs.13578","article-title":"NF-kappaB and HIF crosstalk in immune responses","volume":"283","author":"D'Ignazio","year":"2016","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s40001-021-00570-2","article-title":"The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review","volume":"26","author":"Oliaei","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.pupt.2024.102330_bib5","series-title":"Therapeutics and COVID-19: Living Guideline","year":"2023"},{"key":"10.1016\/j.pupt.2024.102330_bib6","article-title":"Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial","author":"Cannellotto","year":"2021","journal-title":"Emerg. Med. J. : Eng. Manag. J."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib7","article-title":"Hyperbaric oxygen therapy efficacy as an adjuvant for the systemic inflammation reduction in patients with SARS-CoV-2 infection","volume":"4","author":"Toledo-Orozco","year":"2022","journal-title":"J. Clin. Res."},{"key":"10.1016\/j.pupt.2024.102330_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107155","article-title":"Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure","volume":"209","author":"Keller","year":"2023","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jcm12010008","article-title":"Effectiveness of hyperbaric oxygen therapy in SARS-CoV-2 pneumonia: the primary results of a randomised clinical trial","volume":"12","author":"Siewiera","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.pupt.2024.102330_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2024.107744","article-title":"Five sessions of hyperbaric oxygen for critically ill patients with COVID-19-induced ARDS: a randomised, open label, phase II trial","volume":"232","author":"Kjellberg","year":"2024","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2024.102330_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.biopha.2018.10.142","article-title":"Hyperbaric oxygen therapy: antimicrobial mechanisms and clinical application for infections","volume":"109","author":"Memar","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pupt.2024.102330_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/apt.15984","article-title":"A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares","author":"Dulai","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.28920\/dhm51.1.34-43","article-title":"Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: a systematic review and meta-analysis","volume":"51","author":"Hedetoft","year":"2021","journal-title":"Diving and hyperbaric medicine : the journal of the South Pacific Underwater Medicine Society"},{"issue":"11","key":"10.1016\/j.pupt.2024.102330_bib14","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(19)30494-2","article-title":"Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2-3 trial","volume":"20","author":"Oscarsson","year":"2019","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15565-0","article-title":"Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial","volume":"12","author":"Zilberman-Itskovich","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12879-023-08002-8","article-title":"Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial","volume":"23","author":"Kjellberg","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib17","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1038\/s41598-024-53091-3","article-title":"Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial","volume":"14","author":"Hadanny","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.pupt.2024.102330_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060958","article-title":"The hyperoxic-hypoxic paradox","volume":"10","author":"Hadanny","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.pupt.2024.102330_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110224","article-title":"Can hyperbaric oxygen safely serve as an anti-inflammatory treatment for COVID-19?","volume":"144","author":"Kjellberg","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pupt.2024.102330_bib20","first-page":"1","article-title":"COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?","author":"De Maio","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"7","key":"10.1016\/j.pupt.2024.102330_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046738","article-title":"Randomised, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19","volume":"11","author":"Kjellberg","year":"2021","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.pupt.2024.102330_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nri3158","article-title":"Standardizing immunophenotyping for the human immunology project","volume":"12","author":"Maecker","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.pupt.2024.102330_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cyto.b.20432","article-title":"Flowcytometric phenotyping of common variable immunodeficiency","volume":"74","author":"Warnatz","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.pupt.2024.102330_bib24","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s10875-022-01244-2","article-title":"Elevated CD21(low) B cell frequency is a marker of poor immunity to pfizer-BioNTech BNT162b2 mRNA vaccine against SARS-CoV-2 in patients with common variable immunodeficiency","volume":"42","author":"Bergman","year":"2022","journal-title":"J. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.pupt.2024.102330_bib25","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/antiox12122043","article-title":"Comparing the blood response to hyperbaric oxygen with high-intensity interval training-A crossover study in healthy volunteers","volume":"12","author":"Kjellberg","year":"2023","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.pupt.2024.102330_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.pupt.2024.102330_bib27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/bioinformatics\/btp169","article-title":"Data structures and algorithms for analysis of genetics of gene expression with Bioconductor: GGtools 3.x","volume":"25","author":"Carey","year":"2009","journal-title":"Bioinformatics"},{"issue":"43","key":"10.1016\/j.pupt.2024.102330_bib28","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.pupt.2024.102330_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"8","key":"10.1016\/j.pupt.2024.102330_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2016.62","article-title":"The unfolded protein response in immunity and inflammation","volume":"16","author":"Grootjans","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.pupt.2024.102330_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.pupt.2024.102330_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmicb.2014.00296","article-title":"Coronavirus infection, ER stress, apoptosis and innate immunity","volume":"5","author":"Fung","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pupt.2024.102330_bib33","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.3389\/fimmu.2019.03147","article-title":"Insights into the role of endoplasmic reticulum stress in infectious diseases","volume":"10","author":"Choi","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.pupt.2024.102330_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab016","article-title":"The endoplasmic reticulum unfolded protein response - homeostasis, cell death and evolution in virus infections","volume":"45","author":"Prasad","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03707-22","article-title":"SARS-CoV-2 harnesses host translational shutoff and autophagy to optimize virus yields: the role of the envelope (E) protein","volume":"11","author":"Waisner","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib36","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1038\/s41467-021-25551-1","article-title":"Multi-level inhibition of coronavirus replication by chemical ER stress","volume":"12","author":"Shaban","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.pupt.2024.102330_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01123-2020","article-title":"Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue","volume":"56","author":"Aguiar","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2024.102330_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100759","article-title":"The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection","volume":"296","author":"Carlos","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.pupt.2024.102330_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00035-21","article-title":"Endoplasmic reticulum chaperones in viral infection: therapeutic perspectives","volume":"85","author":"Kohli","year":"2021","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.pupt.2024.102330_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.808593","article-title":"The role of unfolded protein response in coronavirus infection and its implications for drug design","volume":"12","author":"Xue","year":"2021","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.pupt.2024.102330_bib41","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S2213-2600(21)00381-7","article-title":"COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions","volume":"9","author":"Lascarrou","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.pupt.2024.102330_bib42","article-title":"People critically ill with COVID-19 exhibit peripheral immune profiles predictive of mortality and reflective of SARS-CoV-2 lung viral burden","volume":"2","author":"Cillo","year":"2021","journal-title":"Cell Rep Med"},{"issue":"2","key":"10.1016\/j.pupt.2024.102330_bib43","article-title":"Dynamic activity in cis-regulatory elements of leukocytes identifies transcription factor activation and stratifies COVID-19 severity in ICU patients","volume":"4","author":"Lam","year":"2023","journal-title":"Cell Rep Med"},{"issue":"24","key":"10.1016\/j.pupt.2024.102330_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246309","article-title":"ER stress induces cell cycle arrest at the G2\/M phase through eIF2alpha phosphorylation and GADD45alpha","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pupt.2024.102330_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-2187-3-15","article-title":"Gadd45 in stress signaling","volume":"3","author":"Liebermann","year":"2008","journal-title":"J. Mol. Signal."},{"issue":"1","key":"10.1016\/j.pupt.2024.102330_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41392-022-01296-1","article-title":"Host cell cycle checkpoint as antiviral target for SARS-CoV-2 revealed by integrative transcriptome and proteome analyses","volume":"8","author":"Sui","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"14","key":"10.1016\/j.pupt.2024.102330_bib47","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/febs.15195","article-title":"Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress","volume":"287","author":"Bartoszewski","year":"2020","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.pupt.2024.102330_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tcb.2012.02.006","article-title":"Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling","volume":"22","author":"Appenzeller-Herzog","year":"2012","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.pupt.2024.102330_bib49","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s13577-021-00495-2","article-title":"mTOR inhibition: a double-edged sword in patients with COVID-19?","volume":"34","author":"Ghasemnejad-Berenji","year":"2021","journal-title":"Hum. Cell"},{"key":"10.1016\/j.pupt.2024.102330_bib50","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fmicb.2014.00222","article-title":"A new paradigm: innate immune sensing of viruses via the unfolded protein response","volume":"5","author":"Smith","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pupt.2024.102330_bib51","first-page":"518","article-title":"The unfolded protein response in virus infections","volume":"5","author":"Chan","year":"2014","journal-title":"Front. Microbiol."}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553924000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:28:40Z","timestamp":1733866120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553924000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":51,"alternative-id":["S1094553924000464"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102330","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperbaric oxygen therapy as an immunomodulatory intervention in COVID-19-induced ARDS: Exploring clinical outcomes and transcriptomic signatures in a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2024.102330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102330"}}